• The Monthly Diabetes
• /
• s.287
• /
• pp.52-55
• /
• 2013

2008년 보건산업진흥원의 "u-Healthcare R&D 기본계획 수립" 연구보고서에서 u-헬스케어 기술개발을 "u-헬스케어 인프라", "u-헬스케어 임상-바이오-생체정보 융합기술", "u-헬스케어 서비스 모델", "자유공모" 등 4개의 사업으로 구성하여 추진할 것을 제안했다. u-헬스케어 인프라는 다양한 형태의 u-헬스케어 기술 및 서비스 지원을 위한 인프라 기술 개발, 전문 인력 양성 및 법 제도 정비 등의 내용을 포함하고, u-헬스케어 임상-바이오-생체정보 융합기술은 임상-바이오-생체정보를 활용하여 u-헬스케어 기반 질병예측 예방, 조기진단, 건강증진 기술개발 등을 포함하며, u-헬스케어 서비스 모델은 국민건강의 안전성과 효율성이 담보되고 산업활성화에 기여할 수 있는 u-헬스케어 서비스 모델 개발 등을 담고 있다. u-헬스케어 자유공모의 내용은 u-헬스케어의 기반이 되는 다양한 인프라, 기술, 서비스를 자유공모 형식으로 발굴함으로써 수용자 중심의 연구개발이 필요함을 제시하였다. u-Health 기술 내용중 세 번째로 u-헬스케어 TRM을 알아본다.

• The Optical Journal
• /
• s.156
• /
• pp.41-51
• /
• 2015

생명공학기술(BT)과 정보통신기술(IT)의 융합으로 모바일 의료기기가 최근 빠른 속도로 발전 하고 있다. 작년부터 시작된 헬스케어 웨어러블 디바이스의 열풍은 IT기업의 헬스케어 시장 진입을 촉진하고 있으며, 스마트폰의 보급으로 인해 의료기기의 활용도와 편리성이 비약적으로 향상되고 있다. 각각의 영역에서 발전하던 의료기기와 스마트기기는 이제 모바일 의료기기라는 하나의 시장에서 만난다. 의료진을 중심으로 개발되던 의료기기는 소비자의 관점에서 재조명되어 보다 유용한 기기로 탈바꿈하고 있다. 단순한 건강관리에서부터 중증질환의 치료에 이르기까지 모바일 의료기기가 제공하는 스마트 헬스케어 솔루션이 중요한 역할을 할 것으로 기대된다. 본 보고서는 최근의 바이오 기술과 헬스케어 스마트기기의 발달을 살펴보고, 모바일 의료기기가 가져올 스마트 헬스케어의 가능성과 극복해야 할 장애물에 대해 분석하였다. 특히 ICT 융합산업이 직면하게 되는 이종 산업의 속성 차이를 이해하는데 주안점을 두었다.

• Journal of Convergence Society for SMB
• /
• v.6 no.4
• /
• pp.79-84
• /
• 2016

A novel diagnosis scheme PCADP(personalized computer aided diagnosis probability) is proposed to overcome the problems mentioned above. PCADP scheme is a personalized diagnosis method based on ontology and it makes the bio-data analysis just a 'process' in the Smart healthcare service system. In addition, we offer a semantics modeling of the smart healthcare ontology framework in order to describe smart healthcare data and service specifications as meaningful representations based on this PCADP. The PCADP scheme is a kind of statistical diagnosis method which has real-time processing, characteristics of flexible structure, easy monitoring of decision process, and continuous improvement.

• Information Systems Review
• /
• v.26 no.1
• /
• pp.289-313
• /
• 2024

Korean pharmaceutical and bio-health companies began applying for FDA approval in 2000. However, drug companies in South Korea are not required to obtain FDA approval to market their products on the South Korean market, and the approval process is highly resource-intensive. This study utilizes event study methodology to examine the information effect of US FDA approval announcements on the stock prices of pharmaceutical and bio-health companies listed on South Korean stock markets. The study's results show that FDA approval announcements caused abnormal increases in corporate stock prices, indicating that these announcements have a transnational information effect on South Korean companies' value. Furthermore, the results show that the impact of FDA approval announcements on stock prices is greater for small companies than mid-sized and large companies and in bio and healthcare industries than in the traditional pharmaceutical industry. This impact is also more significant on the KOSDAQ (Korea Securities Dealers Automated Quotation) companies than the KOSPI (Korean Composite Stock Price Index) companies and after the expansion of stock price limits. These findings signal that the information effect is more significant when regulatory controls are weaker. The results also indicate that obtaining FDA approval brings above-normal returns for companies and that FDA application is a high-risk, high-return investment.

• Proceedings of the Korean Society of Computer Information Conference
• /
• 2012.07a
• /
• pp.55-58
• /
• 2012

최근 u-헬스케어 서비스는 바이오센서 및 스마트 의료 기기의 발달과 의료 데이터의 교환 및 처리를 위한 표준 기술 등이 뒷받침 되면서 서비스의 실체화가 가속화되고 있는 추세이다. u-헬스케어는 유 무선 네트워크와 밀접한 연관을 맺고 있으며, 이러한 유 무선 네트워크의 사용은 기존의 서비스에서 발생 가능한 보안상의 취약점 및 공격이 u-헬스케어 환경에서도 유사하게 나타나며, 개인 의료정보를 주로 다루는 만큼 그 위험성은 더욱 심각하다 사료된다. 이에 본 논문에서는 u-헬스케어의 보안 위협 및 그에 따른 향후 대책방안에 대하여 논하고자 한다.

• Journal of the Korea Convergence Society
• /
• v.9 no.12
• /
• pp.17-24
• /
• 2018

This study attempted to analyze technology convergence structure and key technology research sectors in bio-health. For this, network analysis was performed based on the patent outcomes achieved through national R&Ds. Then, a patent network was analyzed to derive problems and collect data from the National Science & Technology Information Service. With the five groups obtained through the analysis of IPC network and national R&D patents in bio-health based on a research frame network, topics were chosen based on the bio-healthcare technology system. Then, the technology with the greatest ripple effects was derived and compared to other sectors, suggesting a direction for national R&D investments. It is anticipated that this study would make a contribution to a search for R&D investment direction by additionally analyzing overseas patent data and improving correlation analysis between technology convergence and government-led R&D expenses.

• The Journal of the Convergence on Culture Technology
• /
• v.9 no.1
• /
• pp.627-633
• /
• 2023

This study sought to identify the effects of entrepreneurship orientation and self efficacy on entrepreneurial intentions among workers in the bio-healthcare industry in Korea. As interest in health increases in the age of aging, the bio-healthcare industry is attracting a lot of attention for start-ups as an industry that can create high added value, but there are also aspects that take a relatively long time to develop technology, require a lot of money, and have a relatively high probability of failure. In this study, we measured the level of entrepreneurship orientation and self efficacy of bio-healthcare industry workers and identified the degree of influence on entrepreneurial intentions. Studies have shown that innovativeness, progressiveness, and risk-taking among entrepreneurship orientations all have a significant impact on entrepreneurial intention. In addition, self efficacy has been shown to have a mediating effect on the relationship between innovativeness, progressiveness, risk-taking and entrepreneurial intention.

• Journal of Internet Computing and Services
• /
• v.11 no.2
• /
• pp.129-142
• /
• 2010

The ubiquitous healthcare environment is one of the systems that benefit from wireless sensor network. But one of the challenges with wireless sensor network is its high loss rates when transmitting data. Data from the biosensors may not reach the base stations which can result in missing values. This paper proposes the Health Monitor Agent (HMA) to gather data from the base stations, predict missing values, classify symptom patterns into medical conditions, and take appropriate action in case of emergency. This agent is applied in the Ubiquitous Healthcare Environment and uses data from the biosensors and from the patient’s medical history as symptom patterns to recognize medical conditions. In the event of missing data, the HMA uses a predictive algorithm to fill missing values in the symptom patterns before classification. Simulation results show that the predictive algorithm using the HMA makes classification of the symptom patterns more accurate than other methods.

• Journal of the Korea Institute of Information and Communication Engineering
• /
• v.17 no.2
• /
• pp.503-514
• /
• 2013

Mobile Healthcare is a new type of health care services for managing health and life irrespective of time and space by uniting IT and BT. For this service bio-signal measurement using WBAN, and data analysis and monitoring technologies based on mobile devices are essential. Generally, however, mobile application has low compatibility because of the features of mobile platform, we have to redevelop it to support the corresponding platform. In this paper we introduce a Mobile Healthcare System which can function as gateway and monitoring based on hybrid app to create ubiquitous healthcare monitoring system compatible with various mobile devices by overcoming the difference of platforms. The proposed system consists of sensor composition part, monitoring composition part, and server composition part.

• Review of KIISC
• /
• v.33 no.4
• /
• pp.89-93
• /
• 2023

포스트 코로나시대에는 다가올 디지털 인프라 사회에서의 안전하고 편리한 사이버 경제활동을 구현하기 위해서 비대면 인증수단으로서 텔레바이오인식기술의 중요성은 증가할 것으로 전망된다. 이에 따라 바이오인식 관련 국제표준화기구인 ITU-T SG17 Q10(ID Management & Telebiometrics)에서 추진중인 반려동물 개체식별 인증서비스, 헬스케어 응용서비스, 인공지능서비스에서의 생체정보 보호기술 등에 관한 텔레바이오인식기술 표준화 현황을 면밀히 분석하여, 향후 디지털 사회로의 대전환 시대가 도래함에 따른 동물 개체식별 인증서비스, 디지털 헬스케어 응용서비스, 주율주행 응용서비스 등 폭넓게 생활속에 적용되고 진화하고 있는 텔레바이오인식기술 국제표준화 추진현황에 대하여 고찰하고자 한다.